Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Glucocorticoids (Gcs) potently inhibit inflammation, and regulate liver energy metabolism, often acting in a hypoxic environment. We now show hypoxic conditions open a specific GR cistrome, and prevent access of GR to part of the normoxic GR cistrome. Motif analysis identified enrichment of KLF4 binding sites beneath those peaks of GR binding exclusive to normoxia, implicating KLF4 as a pioneer, or co-factor under these conditions. Hypoxia reduced KLF4 expression, however, knockdown of KLF4 did not impair GR recruitment. KLF4 is a known target of microRNAs 103 and 107, both of which are induced by hypoxia. Expression of mimics to either microRNA103, or microRNA107 inhibited GR transactivation of normoxic target genes, thereby replicating the hypoxic effect. Therefore, studies in hypoxia reveal that microRNAs 103 and 107 are potent regulators of GR function. We have now identified a new pathway linking hypoxia through microRNAs 103 and 107 to regulation of GR function.

Original publication

DOI

10.1016/j.mce.2020.111007

Type

Journal article

Journal

Mol Cell Endocrinol

Publication Date

01/12/2020

Volume

518

Keywords

Glucocorticoid receptor, Glucocorticoids, HIF-1α, Hypoxia, MicroRNAs, Cell Hypoxia, Dexamethasone, Gene Expression Regulation, Glucocorticoids, HEK293 Cells, HeLa Cells, Humans, Hypoxia, Kruppel-Like Factor 4, MicroRNAs, Receptors, Glucocorticoid, Signal Transduction